As of 2025-12-28, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (145.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -187685.7%.
The range of the Relative Valuation is (142.31) - (152.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 17.6x | 17.0x |
| Forward P/E multiples | 15.8x - 17.7x | 16.8x |
| Fair Price | (142.31) - (152.16) | (145.94) |
| Upside | -183023.8% - -195677.5% | -187685.7% |
| Date | P/E |